Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

62.32
Delayed Data
As of Aug 25
 -0.41 / -0.65%
Today’s Change
47.97
Today|||52-Week Range
64.00
+17.99%
Year-to-Date
Tight Trading on Thursday with Stocks Ending Lower
Aug 25 / GuruFocus News - Paid Partner Content
Stocks are hot again. But are they too hot?
Aug 16 / CNNMoney.com
3 Reasons Gilead Sciences Inc. Stock Could Fall
Aug 25 / MotleyFool.com - Paid Partner Content
Inovio Expands Enrollment in Ebola Vaccine Phase I Study
Aug 15 / Zacks.com - Paid Partner Content
Healthcare Drug Pricing a Factor for the Market on Wednesday
Aug 24 / GuruFocus News - Paid Partner Content
Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Aug 14 / MotleyFool.com - Paid Partner Content
Merck Offers Value and Steady Dividend Growth
Aug 24 / GuruFocus News - Paid Partner Content
Top 3 Research Reports for August 12, 2016
Aug 12 / Zacks.com - Paid Partner Content
Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors
Aug 23 / TheStreet.com - Paid Partner Content
After Opdivo's Failure, Is Merck a Better Buy Than Bristol-Myers?
Aug 10 / MotleyFool.com - Paid Partner Content
ETFs in Focus on Pfizer's Medivation Acquisition
Aug 22 / Zacks.com - Paid Partner Content
Immune Design (IMDZ) Posts Wider-than-Expected Q2 Loss
Aug 10 / Zacks.com - Paid Partner Content
2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now
Aug 18 / MotleyFool.com - Paid Partner Content
Gilead Sciences Inc. Stock in 3 Charts
Aug 09 / MotleyFool.com - Paid Partner Content
How Will Merck (MRK) Stock React to Potential Medivation Bid?
Aug 17 / TheStreet.com - Paid Partner Content
Allergan setback prompts healthcare slide
Aug 08 / FT.com - Paid Partner Content
Gilead: breaking the fever
Aug 17 / FT.com - Paid Partner Content
Bristol-Myers' value plunges $23bn after cancer drug fails trial
Aug 05 / FT.com - Paid Partner Content
Pfizer's Bold Bid to Conquer Cancer
Aug 16 / MotleyFool.com - Paid Partner Content